Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc.

NASDAQ:ASMB

Overview | Financials
Company Name Assembly Biosciences, Inc.
Symbol ASMB
Currency USD
Price 18.1
Market Cap 114,854,636
Dividend Yield 0%
52-week-range 7.68 - 19.93
Industry Biotechnology
Sector Healthcare
CEO Mr. Jason A. Okazaki
Website https://www.assemblybio.com

An error occurred while fetching data.

About Assembly Biosciences, Inc.

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing

Related Stocks

Lipocine Inc. logo

Lipocine Inc.

LPCN

5.04 USD

SAB Biotherapeutics, Inc. logo

SAB Biotherapeutics, Inc.

SABS

2.76 USD

aTyr Pharma, Inc. logo

aTyr Pharma, Inc.

LIFE

1.9 USD

Miromatrix Medical Inc. logo

Miromatrix Medical Inc.

MIRO

3.39 USD

Wave Life Sciences Ltd. logo

Wave Life Sciences Ltd.

WVE

14.61 USD

Vigil Neuroscience, Inc. logo

Vigil Neuroscience, Inc.

VIGL

3.99 USD

Clearside Biomedical, Inc. logo

Clearside Biomedical, Inc.

CLSD

1.15 USD

Eliem Therapeutics, Inc. logo

Eliem Therapeutics, Inc.

ELYM

5.11 USD

Financials

Numbers are in millions USD

Numbers are in millions USD